Stevenson RW - Search Results

1

Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.

Martin WH, Hoover DJ, Armento SJ, Stock IA, McPherson RK, Danley DE, Stevenson RW, Barrett EJ, Treadway JL. Martin WH, et al. Among authors: stevenson rw. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1776-81. doi: 10.1073/pnas.95.4.1776. Proc Natl Acad Sci U S A. 1998. PMID: 9465093 Free PMC article.

2

Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene.

Treadway JL, Hargrove DM, Nardone NA, McPherson RK, Russo JF, Milici AJ, Stukenbrok HA, Gibbs EM, Stevenson RW, Pessin JE. Treadway JL, et al. Among authors: stevenson rw. J Biol Chem. 1994 Nov 25;269(47):29956-61. J Biol Chem. 1994. PMID: 7961994 Free article.

3

Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia.

Stevenson RW, McPherson RK, Genereux PE, Danbury BH, Kreutter DK. Stevenson RW, et al. Metabolism. 1991 Dec;40(12):1268-74. doi: 10.1016/0026-0495(91)90027-t. Metabolism. 1991. PMID: 1961119

4

The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat diet.

Stevenson RW, McPherson RK, Persson LM, Genereux PE, Swick AG, Spitzer J, Herbst JJ, Andrews KM, Kreutter DK, Gibbs EM. Stevenson RW, et al. Diabetes. 1996 Jan;45(1):60-6. doi: 10.2337/diab.45.1.60. Diabetes. 1996. PMID: 8522061

5

Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.

Stevenson RW, Hutson NJ, Krupp MN, Volkmann RA, Holland GF, Eggler JF, Clark DA, McPherson RK, Hall KL, Danbury BH, et al. Stevenson RW, et al. Diabetes. 1990 Oct;39(10):1218-27. doi: 10.2337/diab.39.10.1218. Diabetes. 1990. PMID: 2210074

6

Actions of the novel antidiabetic agent englitazone in rat hepatocytes.

Blackmore PF, McPherson RK, Stevenson RW. Blackmore PF, et al. Among authors: stevenson rw. Metabolism. 1993 Dec;42(12):1583-7. doi: 10.1016/0026-0495(93)90154-g. Metabolism. 1993. PMID: 8246773

7

Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes.

Kreutter DK, Andrews KM, Gibbs EM, Hutson NJ, Stevenson RW. Kreutter DK, et al. Among authors: stevenson rw. Diabetes. 1990 Nov;39(11):1414-9. doi: 10.2337/diab.39.11.1414. Diabetes. 1990. PMID: 2227113

8

Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo.

Hargrove DM, Nardone NA, Persson LM, Andrews KM, Shepherd KL, Stevenson RW, Parker JC. Hargrove DM, et al. Among authors: stevenson rw. Metabolism. 1996 Mar;45(3):404-9. doi: 10.1016/s0026-0495(96)90297-8. Metabolism. 1996. PMID: 8606650

9

Benzyloxazolidine-2,4-diones as potent hypoglycemic agents.

Dow RL, Bechle BM, Chou TT, Clark DA, Hulin B, Stevenson RW. Dow RL, et al. Among authors: stevenson rw. J Med Chem. 1991 May;34(5):1538-44. doi: 10.1021/jm00109a003. J Med Chem. 1991. PMID: 2033578

10

Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short- or long-term administration.

Hargrove DM, Nardone NA, Persson LM, Parker JC, Stevenson RW. Hargrove DM, et al. Among authors: stevenson rw. Metabolism. 1995 Sep;44(9):1231-7. doi: 10.1016/0026-0495(95)90021-7. Metabolism. 1995. PMID: 7666800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters